PMID- 28249933
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20190228
IS  - 1078-0432 (Print)
IS  - 1078-0432 (Linking)
VI  - 23
IP  - 5
DP  - 2017 Mar 1
TI  - Correction: PI3K Pathway Inhibition Achieves Potent Antitumor Activity in
      Melanoma Brain Metastases In Vitro and In Vivo.
PG  - 1361
LID - 10.1158/1078-0432.CCR-16-3165 [doi]
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Clin Cancer Res
JT  - Clinical cancer research : an official journal of the American Association for
      Cancer Research
JID - 9502500
EFR - Clin Cancer Res. 2016 Dec 1;22(23 ):5818-5828. PMID: 27307593
EDAT- 2017/03/03 06:00
MHDA- 2017/03/03 06:01
CRDT- 2017/03/03 06:00
PHST- 2017/03/03 06:00 [entrez]
PHST- 2017/03/03 06:00 [pubmed]
PHST- 2017/03/03 06:01 [medline]
AID - 23/5/1361 [pii]
AID - 10.1158/1078-0432.CCR-16-3165 [doi]
PST - ppublish
SO  - Clin Cancer Res. 2017 Mar 1;23(5):1361. doi: 10.1158/1078-0432.CCR-16-3165.